This content is from: Premium

This Red-Hot Sector Is Where the (Private) Money Is

Managers continue to load up on private investments in biopharma and other health care companies.

The high-flying FAANG stocks — Facebook, Amazon, Alphabet, Netflix, and Google — may still be attracting a lot of investor attention in the public markets. But health care companies, especially fledgling biopharmaceutical companies, are the most popular plays in the private investment world.IPO specialist Renaissance Capital said in a new

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content